Mayo Clinic CEO Gianrico Farrugia, M.D., and other Mayo leaders have been in regular contact with the Trump administration, Sen. Amy Klobuchar, Sen. Tina Smith and others to help find solutions to shortages in testing supplies and equipment. Mayo Clinic leaders and the Government Engagement team also have encouraged the administration and members of Congress to grant further regulatory flexibility to expedite potential serologic testing and treat non-emergent cases via telehealth and in non-hospital settings.